Cationic Oil-in-Water Emulsions for Stable RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current delivery systems for nucleic acid molecules, particularly RNA, face challenges such as rapid degradation and low efficiency in vivo due to cellular nucleases, requiring the development of stable and effective delivery methods for therapeutic and vaccine applications.
Innovation Solution
The use of cationic oil-in-water emulsions with high concentrations of cationic lipids and a defined oil:cationic lipid ratio, which interact with negatively charged molecules to anchor them to emulsion particles, enhancing stability and cellular uptake.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If nucleic acid molecules are injected in vivo, then gene delivery can be achieved, but the half life is only about 70 seconds due to cellular and serum nucleases
Solution Approach 1:
The patent uses cationic lipids as intermediary carriers to deliver nucleic acid molecules. The cationic lipids form complexes with the negatively charged nucleic acids, protecting them from nucleases while facilitating cellular uptake. This mediator approach resolves the contradiction by providing both protection (extending half-life) and delivery capability.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the delivery system by using cationic lipids with specific charge densities and molecular structures. These parameter changes enable the formation of stable nucleic acid-lipid complexes that resist nuclease degradation while maintaining cellular permeability, thus extending half-life without sacrificing delivery efficiency.
2Duration of action of moving object
If chemical modifications are made to increase stability of injected RNA, then half life can be extended, but cytotoxic effects increase or function is lost
Solution Approach 1:
Instead of chemically modifying the RNA itself (which causes cytotoxicity), the patent introduces cationic lipids as external mediators that provide protection. The RNA remains chemically unchanged, preserving its function and reducing cytotoxic effects, while the cationic lipid carrier provides the necessary stability and protection from nucleases.
Solution Approach 2:
The patent separates the protection function from the RNA molecule itself by using a distinct cationic lipid carrier. The RNA retains its native structure and function, while the cationic lipid component provides the protective function, thus avoiding the cytotoxic effects associated with chemical modifications of the RNA.
3Quantity of substance
If large doses of nucleic acid are administered to obtain potent immune responses, then vaccine potency increases, but delivery system requirements become more stringent
Solution Approach 1:
The patent optimizes parameters of the cationic lipid delivery system, including charge density, molecular weight, and lipid-to-nucleic acid ratio, to achieve efficient delivery of large nucleic acid doses. By carefully controlling these parameters, the system can handle high quantities of nucleic acid without becoming overly complex, maintaining relatively simple formulation and administration protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases the efficiency of nucleic acid delivery, stabilizes RNA molecules against degradation, and enhances the immune response by increasing the amount of encoded protein antigen produced, thereby improving the potency and immunogenicity of RNA vaccines.
Implementation Method 1
The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles
Data Source
AI summary
This invention generally relates to cationic oil-in-water emulsions that contain high concentrations of cationic lipids and have a defined oil:lipid ratio. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles. The cationic emulsions described herein are useful for delivering negatively charged molecules, such as nucleic acid molecules to cells, and for formulating nucleic acid-based vaccines.